Release Agreement AmendmentRelease Agreement Amendment • May 25th, 2022 • Tyme Technologies, Inc. • Pharmaceutical preparations
Contract Type FiledMay 25th, 2022 Company IndustryThis Amendment (the “Amendment”), effective as of April 18, 2022, is entered into by and between Tyme Technologies, Inc., a Delaware corporation (the “Company”), and Michael Demurjian (the “Stockholder”).